^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
DecisionDx®-CMSeq

Type:
Laboratory Developed Test
Related tests:

Details

Evidence
Twitter
DecisionDx-CMSeq is a 3-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to cutaneous melanoma in melanoma tumor tissue. The test includes hotspot mutations in the genes BRAF, NRAS and KIT.
Cancer:
Cutaneous Melanoma
Gene:
BRAF (B-raf proto-oncogene), KIT (KIT proto-oncogene, receptor tyrosine kinase), NRAS (Neuroblastoma RAS viral oncogene homolog)
Method:
Next-Generation Sequencing (NGS)